Tuberculosis (TB) is a bacterial disease primarily of the lungs. It is airborne and spreads when someone with active TB disease coughs, laughs or sings.

To control the spread of TB in Oregon, the TB Control Program works with local health departments and private medical providers to: 1) identify and treat TB disease; 2) identify, evaluate, and treat newly infected contacts to infectious TB cases; 3) screen high-risk populations for TB infection. The TB Program provides lab testing, technical assistance, TB medications and analysis of surveillance data to assist with accomplishing these goals.

Nationwide shortage of Isoniazid (INH) and tuberculin affecting Oregon

Get information and guidance regarding the ongoing shortages of INH and Tubersol®.  

• Contact Heidi Behm at 971-673-0169 or heidi.behm@state.or.us with questions or concerns.

---

New LTBI Treatment Regimen

On December 9, 2011, the CDC released recommendations on the use of a new 12 dose regimen consisting of isoniazid and rifapentine to treat latent TB infection. This represents a major advancement in preventing future cases of TB disease.

• Read the recommendations
• See our Fact Sheet: 12-dose Isoniazid-Rifapentine Regimen for Treatment of Latent TB Infection (LTBI) 
• Read a summary of all the current treatment options for LTBI  
• LTBI Treatment Regimens                            

• Case Forms
• Contact Investigation Forms
• Treatment of LTBI Forms
• Transfer Forms (Case, Contact, LTBI, B-waiver)
• Reimbursement Forms

TB Control Program Surveys

• Contact Evaluation and LTBI Treatment: Populations and Challenges

Guidelines

• TB Guidelines